radiation
Showing 26 - 50 of 180
Pancreatic Cancer, Metastatic Pancreatic Cancer Trial in Boston (Niraparib, Dostarlimab, Radiation)
Active, not recruiting
- Pancreatic Cancer
- Metastatic Pancreatic Cancer
- Niraparib
- +2 more
-
Boston, Massachusetts
- +2 more
Oct 18, 2021
Stem Cell Transplant Complications, Graft Vs Host Disease, Myeloid Leukemia, Acute Trial in Boston (radiation, drug, biological,
Recruiting
- Stem Cell Transplant Complications
- +4 more
- Radiation
- +7 more
-
Boston, MassachusettsDana Farber Cancer Institute
Jan 19, 2023
Prostate Cancer Trial in Washington, Baltimore (drug, procedure, radiation)
Completed
- Prostate Cancer
- Leuprolide Acetate
- +4 more
-
Washington, District of Columbia
- +2 more
Jul 11, 2022
Stage IIIA NSCLC Trial in Cleveland (Cisplatin, Etoposide, Pembrolizumab)
Terminated
- Stage IIIA Non-Small Cell Lung Cancer
- Cisplatin
- +3 more
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Dec 15, 2022
Gastric Cancer, Gastroesophageal-junction Cancer Trial in Wuhan, Nanjing, Taiyuan (Tislelizumab, S-1, Oxaliplatin)
Not yet recruiting
- Gastric Cancer
- Gastroesophageal-junction Cancer
- Tislelizumab
- +4 more
-
Wuhan, Hubei, China
- +2 more
Jan 16, 2023
Prostate Cancer Trial in Washington, Baltimore (Leuprolide Acetate, Docetaxel, Bicalutamide)
Active, not recruiting
- Prostate Cancer
- Leuprolide Acetate
- +4 more
-
Washington, District of Columbia
- +1 more
Mar 29, 2022
Hepatocellular Carcinoma, Biliary Tract Cancer Trial in Boston (Tremelimumab, Durvalumab, Radiation)
Recruiting
- Hepatocellular Carcinoma
- Biliary Tract Cancer
- Tremelimumab
- +2 more
-
Boston, Massachusetts
- +1 more
Apr 22, 2021
Lung Cancer Trial in Nashville (Docetaxel, Gemcitabine, Carboplatin)
Non Small Cell Lung Cancer, Stage III Non-small-cell Lung Cancer Trial in United States (device, drug, radiation, procedure)
Active, not recruiting
- Non Small Cell Lung Cancer
- Stage III Non-small-cell Lung Cancer
- Durvalumab
- +4 more
-
Chicago, Illinois
- +3 more
Jan 18, 2023
Resectable Esophageal Cancer, GastroEsophageal Cancer Trial in Madison (combination product, drug, radiation)
Active, not recruiting
- Resectable Esophageal Cancer
- GastroEsophageal Cancer
- Avelumab combined with Chemoradiation
- +3 more
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Mar 28, 2022
Pancreatic Cancer Trial in Hangzhou (Radiation, Anti-PD-1 Antibody)
Recruiting
- Pancreatic Cancer
- Radiation
- Anti-PD-1 Antibody
-
Hangzhou, Zhejiang, ChinaHangzhou Cancer Hospital
Feb 9, 2021
Rectal Cancer Trial in Providence (BYL719, Capecitabine, Radiation)
Terminated
- Rectal Cancer
- BYL719
- +2 more
-
Providence, Rhode IslandRhode Island Hospital and The Miriam Hospital
Mar 11, 2021
Head Neck Cancer, Squamous Cell Carcinoma of Head and Neck, Oral Cavity Squamous Cell Carcinoma Trial in Nashville
Not yet recruiting
- Head and Neck Cancer
- +9 more
- Zimberelimab
- +3 more
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Aug 9, 2022
Cancer of Rectum, Cancer of the Rectum, Tumor, Rectum Trial in Saint Louis (Radiation, Oxaliplatin, Leucovorin)
Completed
- Cancer of Rectum
- +6 more
- Radiation
- +3 more
-
Saint Louis, MissouriWashington University School of Medicine
Feb 10, 2021
Head and Neck Squamous Cell Carcinomas Trial in Guanzhou (drug, procedure, radiation)
Recruiting
- Head and Neck Squamous Cell Carcinomas
- Tislelizumab(neoadjuvant)
- +6 more
-
Guanzhou, Guangdong, ChinaSun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Oct 28, 2022
Childhood CNS Tumor Trial in Washington (genetic, radiation, drug)
Not yet recruiting
- Childhood CNS Tumor
- SGT-53
- +4 more
-
Washington, District of ColumbiaChildren's National Medical Center
Feb 7, 2022
Glioblastoma, Glioblastoma Multiforme Trial in United States (drug, other, radiation)
Recruiting
- Glioblastoma
- Glioblastoma Multiforme
- BPM31510
- +3 more
-
Los Angeles, California
- +3 more
May 31, 2022
Prostate Cancer Metastatic to Bone Trial in Salt Lake City (Radium Ra 223 Dichloride, Radiation)
Active, not recruiting
- Prostate Cancer Metastatic to Bone
- Radium Ra 223 Dichloride
- Radiation
-
Salt Lake City, UtahHuntsman Cancer Institute
Sep 20, 2021
High Grade Recurrent Glioma and Newly Diagnosed Glioblastoma Trial in Fullerton, Newport Beach, Santa Monica (ABI-009,
Active, not recruiting
- High Grade Recurrent Glioma and Newly Diagnosed Glioblastoma
- ABI-009
- +5 more
-
Fullerton, California
- +2 more
Jun 13, 2022
Triple Negative Breast Cancer, TNBC - Triple-Negative Breast Cancer, Breast Cancer Trial in United States (Pembrolizumab,
Recruiting
- Triple Negative Breast Cancer
- +2 more
- Pembrolizumab
- +2 more
-
Basking Ridge, New Jersey
- +6 more
Sep 15, 2021
Esophageal Tumors Trial (radiation, drug, biological)
Not yet recruiting
- Esophageal Neoplasms
- Radiation
- +2 more
- (no location specified)
Oct 16, 2023
Rectal Tumors Trial in Guangzhou (Oxaliplatin, capecitabine, Radiation)
Active, not recruiting
- Rectal Neoplasms
- Oxaliplatin
- +2 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University, Cancer Center
Jul 26, 2022
Human Papilloma Virus, Squamous Cell Carcinoma, Squamous Cell Carcinoma of the Head and Neck Trial in Chicago (Carboplatin,
Recruiting
- Human Papilloma Virus
- +4 more
- Carboplatin
- +7 more
-
Chicago, IllinoisUniversity Of Chicago Medicine Comprehensive Cancer Center
Jun 3, 2022